Document Detail

Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.
MedLine Citation:
PMID:  21031368     Owner:  NLM     Status:  Publisher    
Engineering of mammalian production cell lines to improve titer and quality of biopharmaceuticals is a top priority of the biopharmaceutical manufacturing industry providing protein therapeutics to patients worldwide. While many engineering strategies have been successful in the past decade they were often based on the over-expression of a single transgene and therefore limited to addressing a single bottleneck in the cell's production capacity. We provide evidence that ectopic expression of the global metabolic sensor and processing protein mammalian target of rapamycin (mTOR), simultaneously improves key bioprocess-relevant characteristics of Chinese hamster ovary (CHO) cell-derived production cell lines such as cell growth (increased cell size and protein content), proliferation (increased cell-cycle progression), viability (decreased apoptosis), robustness (decreased sensitivity to sub-optimal growth factor and oxygen supplies) and specific productivity of secreted human glycoproteins. Cultivation of mTOR-transgenic CHO-derived cell lines engineered for secretion of a therapeutic IgG resulted in antibody titers of up to 50 pg/cell/day, which represents a four-fold increase compared to the parental production cell line. mTOR-based engineering of mammalian production cell lines may therefore have a promising future in biopharmaceutical manufacturing of human therapeutic proteins. Biotechnol. Bioeng. © 2010 Wiley Periodicals, Inc.
Imke A J Dreesen; Martin Fussenegger
Related Documents :
3119238 - Stabilization of a reactive, electrophilic carcinogen, benzo[a]pyrene diol epoxide, by ...
2784538 - Different mutations responsible for the elevated sister-chromatid exchange frequencies ...
1375328 - Nuclease modification in chinese hamster cells hypersensitive to dna cross-linking agen...
9576878 - Isolation of a chinese hamster fibroblast variant defective in dihydroxyacetonephosphat...
25070628 - Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellula...
23314658 - Brief maternal exposure of rats to the xenobiotics dibutyl phthalate or diethylstilbest...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-10-28
Journal Detail:
Title:  Biotechnology and bioengineering     Volume:  -     ISSN:  1097-0290     ISO Abbreviation:  -     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7502021     Medline TA:  Biotechnol Bioeng     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, CH-4058 Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Integrated palladium-catalyzed arylation of heavier Group 14 hydrides.
Next Document:  A highly efficient and extensively reusable "dip catalyst" based on a silver-nanoparticle-embedded p...